Skip to main content
. 2022 Sep 15;13:947216. doi: 10.3389/fgene.2022.947216

FIGURE 5.

FIGURE 5

(A) Heatmap showing the connections between clinicopathologic factors and high- and low-risk groups; (B) Bar chart for GO enrichment of DEGs between high- and low-risk; (C) Bubble graph for KEGG pathways of DEGs between high- and low-risk; (D) Gene set enrichment analysis (GSEA) showed the significantly enriched hallmarks of tumor sets based on the risk signature in TCGA.